SmartInsider

Research suggests that directors know their companies better than the market. For many investors it is intuitive that following the trading patterns of directors and other company insiders can lead to successful investing. They often have detailed knowledge about their companies and generally know when the shares are incorrectly valued. However, that is not always true and with large numbers of trades reported every day on exchanges around the world, it is difficult to know which to follow.  

 SmartInsider provides valuable insight by supplementing and analysing reported transactions to achieve real insight with a focus on identifying the ‘Smart Insiders’ and highlighting the stand-out transactions they make. Our proven track-record and thirty year pedigree are backed by more recent statistical analysis of historical data.

 Our service offers director dealing reports, company reports and monthly summaries with a fully interactive website for further research. We can also provide quant feeds and customised alerts to suit every need at the frequency preferred.  SmartInsider covers all markets with a regulatory requirement to report insider activity, over 60,000 companies across 55 markets.

Astera Labs Inc: 1 director

A director at Astera Labs Inc sold 18,264 shares at 101.524USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Akero Therapeutics Inc: 1 director

A director at Akero Therapeutics Inc sold 30,000 shares at 51.163USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

GeneDx Holdings Corp: 2 directors

Two Directors at GeneDx Holdings Corp sold/sold after exercising options 8,498 shares at 93.000USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

BeOne Medicines Ltd: 1 director

A director at BeOne Medicines Ltd sold after exercising options/sold 49,395 shares at 18.827USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

Rhythm Pharmaceuticals Inc: 4 directors

Four Directors at Rhythm Pharmaceuticals Inc sold after exercising options/sold 69,478 shares at between 77.130USD and 80.749USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...

Astera Labs Inc: 1 director

A director at Astera Labs Inc sold 18,264 shares at 101.524USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Akero Therapeutics Inc: 1 director

A director at Akero Therapeutics Inc sold 30,000 shares at 51.163USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

GeneDx Holdings Corp: 2 directors

Two Directors at GeneDx Holdings Corp sold/sold after exercising options 8,498 shares at 93.000USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

BeOne Medicines Ltd: 1 director

A director at BeOne Medicines Ltd sold after exercising options/sold 49,395 shares at 18.827USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

Rhythm Pharmaceuticals Inc: 4 directors

Four Directors at Rhythm Pharmaceuticals Inc sold after exercising options/sold 69,478 shares at between 77.130USD and 80.749USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch